Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "amarillo"


25 mentions found


Pills of Misoprostol, used to terminate early pregnancies, are displayed in a pharmacy in Provo, Utah, May 12, 2022. New York and California are stockpiling massive quantities of an alternative abortion medication in case a federal judge's order suspending the Food and Drug Administration's approval of the main drug mifepristone goes into effect later this week. Kathy Hochul on Tuesday ordered the state health department to immediately start purchasing 150,000 doses of misoprostol, a five-year supply of the pill. Gavin Newsom said California has secured 2 million pills of misoprostol. The second pill is used as a standalone abortion medication in parts of the world.
Cineworld has sought to exit its leases for 130 theaters in the US. A bankruptcy court in Texas has already approved its plan to walk away from 47 of those locations. Cineworld filed for Chapter 11 bankruptcy in September. So far, the Texas bankruptcy court overseeing the proceedings has approved the company's plan to exit 47 leases, according to court filings. The North American box office hit $7.4 billion in 2022, according to Comscore, down from over $11 billion in 2019 and 2018.
Abortion-Pill Ruling Draws Muted Response From GOP
  + stars: | 2023-04-10 | by ( Michelle Hackman | ) www.wsj.com   time to read: 1 min
Former Vice President Mike Pence was one of a few Republicans to publicly comment on the decision. Republican lawmakers’ muted reaction to a federal judge’s ruling to suspend access to the abortion pill is the latest sign that the GOP’s legal success in limiting access to abortions is causing the party political headaches. Friday’s ruling, issued by U.S. District Judge Matthew Kacsmaryk, suspends the Food and Drug Administration’s approval of the pill, known as mifepristone, which is now used in a majority of abortions in the U.S. The judge, a Trump appointee who sits in Amarillo, Texas, delayed the impact of his decision for a week while the Biden administration appeals.
Kacsmaryk, an appointee of Republican former President Donald Trump, stayed his ruling for seven days to allow the Biden administration time to appeal. The Justice Department asked that a stay be entered by April 13, and that it remain in place until all appeals, including if necessary to the Supreme Court, are resolved. Lawyers for the anti-abortion groups that challenged the FDA's approval of mifepristone did not immediately respond to requests for comment. The conflicting rulings could foreshadow a resolution by the Supreme Court, which last June overturned the 1973 Roe v. Wade decision that eliminated a constitutional right to abortion. The Supreme Court has a 6-3 conservative majority.
"We are discussing ways to offer them legal support," one of the sources said of manufacturers and retail pharmacies. Major U.S. manufacturers of abortion pills include GenBioPro Inc and Danco Laboratories. Walgreens said in March it would not dispense abortion pills in the 20 states where it risked breaking the law. Discussions between the Biden administration and pill manufacturers and pharmacies over the issue have been ongoing for months, sources said, but Friday's decision brings fresh urgency. It is unclear whether the administration is considering following in California Governor Gavin Newsom's footsteps by withholding federal contracts from chains that suspend abortion pill sales.
Texas Abortion-Pill Ruling Ignites New National Battle
  + stars: | 2023-04-09 | by ( Laura Kusisto | ) www.wsj.com   time to read: 1 min
Photo: Michael Noble Jr. for The Wall Street JournalMifepristone is sold under the brand name Mifeprex and in a generic version. A ruling by a Texas judge suspending approval of the abortion pill sets off a new national fight over women’s access to abortion less than a year after the Supreme Court withdrew constitutional protections for the procedure. In a 67-page ruling on Friday, U.S. District Judge Matthew Kacsmaryk, a Trump appointee who sits in Amarillo, said the U.S. Food and Drug Administration made a series of legal errors in approving the pill, known as mifepristone, for sale. He delayed the impact of his decision for a week while the Biden administration appeals and seeks an emergency stay.
Aspen Tucker, 29, has been working as a travel nurse since earning his associate's degree in 2020. In 2022, two years after becoming a travel nurse, Tucker brought home about $187,000 for the year, per CNBC. On average, travel nurses make about 50% more than staff nurses due to high demand. Travel nurses get a living expense stipend and a housing stipend, which are considered reimbursements, not income, she said. While under contract, travel nurses have health insurance, but not when they're between jobs.
April 7 (Reuters) - The federal judge who on Friday suspended approval of the abortion pill mifepristone is a former Christian legal activist whose small courthouse in Amarillo, Texas, has become a go-to destination for conservatives challenging Biden administration policies. U.S. District Judge Matthew Kacsmaryk, an appointee of former Republican President Donald Trump, had a long track record of opposing abortion and LGBTQ rights before the U.S. Senate confirmed him in 2019 to a life-tenured position as a federal judge. FAVORED VENUESince then, his courthouse has become a favored venue for conservative legal activists and Republican state attorneys general pursuing lawsuits seeking to halt aspects of Democratic President Joe Biden's agenda - often with success. In October, Kacsmaryk vacated Biden administration guidance requiring employers to allow transgender workers to dress and use bathrooms consistent with their gender identities. Reporting by Nate Raymond in Boston, Editing by Alexia Garamfalvi, Bill Berkrot and Diane CraftOur Standards: The Thomson Reuters Trust Principles.
"I absolutely love living in Spartanburg and being a travel nurse. I'm able to have a high salary as a travel nurse, but come back to where the cost of living is low." Tucker began his career as a travel nurse after earning an associate's degree. "I'm away from home, I'm away from family, I'm away from my dog," says Tucker. CHECK OUT: 29-year-old travel nurse seized a chance to make $187,000 and only work 9 months a year: It’s ‘a once-in-a-lifetime opportunity’
Pool via REUTERSApril 8 (Reuters) - The federal judge who on Friday suspended approval of the abortion pill mifepristone is a former Christian legal activist whose small courthouse in Amarillo, Texas, has become a go-to destination for conservatives challenging Biden administration policies. U.S. District Judge Matthew Kacsmaryk, an appointee of former Republican President Donald Trump, had a long track record of opposing abortion and LGBTQ rights before the U.S. Senate confirmed him in 2019 to a life-tenured position as a federal judge. When anti-abortion groups in November filed a lawsuit challenging the U.S. Food and Drug Administration's more than two-decade old approval of the abortion pill mifepristone, they filed in Amarillo, guaranteeing the case would be heard by Kacsmaryk. FAVORED VENUESince then, his courthouse has become a favored venue for conservative legal activists and Republican state attorneys general pursuing lawsuits seeking to halt aspects of Democratic President Joe Biden's agenda - often with success. While the district's chief judge could order cases be reallocated, he has not.
The Biden administration is seeking an emergency stay of Kacsmaryk's order from the New Orleans-based 5th U.S. The 5th Circuit has a conservative reputation, with 12 of its 16 active judges appointed by Republican presidents. The FDA could then petition the U.S. Supreme Court for an emergency stay. Regardless of whether it wins an emergency stay of the injunction, the FDA will continue its appeal of Kacsmaryk's preliminary injunction. Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.
A federal judge on Friday suspended approval of the abortion pill, in a preliminary ruling against the Food and Drug Administration that could limit women’s access to the most common method for ending a pregnancy. U.S. District Judge Matthew Kacsmaryk of Amarillo, Texas, said in a 67-page ruling that the FDA made a series of legal errors in approving the pill for sale in the U.S. The judge suspended approval of the pill but delayed the impact of his decision for a week to give the Biden administration a chance to appeal.
Adding to the volatile legal landscape around abortion, a federal judge in Washington state on Friday issued a seemingly conflicting injunction that prevented federal regulators from altering access to the same abortion drug. Kacsmaryk's ruling is a preliminary injunction that would essentially ban sales of mifepristone while the case by anti-abortion groups before him continues. By choosing to sue in Amarillo, the plaintiffs ensured that the case would go before Kacsmaryk, a conservative former Christian activist. Circuit Court of Appeals, which has a conservative reputation, with more than two-thirds of its judges appointed by Republican presidents. The FDA in January said that the government for the first time will allow mifepristone to be dispensed at retail pharmacies.
Texas Judge Matthew Kacsmaryk issued a ruling Friday that jeopardizes the availability of a key abortion drug. An antiabortion legal group had sought to revoke or suspend the FDA's approval of the drug mifepristone. In the ruling, Judge Matthew Kacsmaryk, who was appointed by former President Donald Trump, imposed a stay on the Food & Drug Administration's approval of the drug, arguing that it was unlawful. Revoking the FDA's approval of mifepristone could immediately upend abortion access for countless women across the country. The medication mifepristone typically works as part of a two-medication regimen to terminate pregnancies.
April 7 (Reuters) - A federal judge on Friday halted federal regulators' approval of the abortion pill mifepristone while a legal challenge proceeds, partially granting a request by anti-abortion groups and dealing another setback to abortion rights in the United States. A White House official said they are reviewing the abortion ruling. Kacsmaryk's ruling is a preliminary injunction that would essentially ban sales of mifepristone while the case before him continues. Some abortion providers have said that if mifepristone is unavailable, they would switch to a regimen using only misoprostol for a medication abortion. During the hearing in the case, the judge raised questions about the regulatory process used by the FDA.
Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. A federal judge in Texas on Friday stayed the Food and Drug Administration's approval of the abortion pill mifepristone, but delayed the ruling taking effect for a week, giving the Biden administration time to appeal. The Food and Drug Administration, abortion pill maker Danco Laboratories and the anti-abortion group Alliance Defending Freedom presented their arguments before the court. The alliance represents a coalition of physicians opposed to abortion called the Alliance for Hippocratic Medicine, which sued the FDA in November over its approval of mifepristone. It took more than four years from the filing of the initial application until the pill was approved.
Here is a snapshot of pending and passed legislation seeking to restrict or protect access in 2023. KANSAS: Although Kansans voted in favor of state abortion rights on a ballot measure last year, the Republican-led state Senate has passed a prohibition on prescribing abortion pills via telemedicine. The Republican-led state is currently enforcing a total abortion ban, with exceptions for rape, incest or the life of the mother. MONTANA: The Republican-led state Senate has passed a bill seeking to overturn a 1999 state Supreme Court ruling that found that the state constitution protected a right to abortion. SOUTH CAROLINA: Despite the fact that the state Supreme Court recently struck down a six-week abortion ban in a 3-2 vote, Republicans have introduced a near-total abortion ban and a six-week ban this year.
Washington state purchases three-year supply of abortion pill
  + stars: | 2023-04-05 | by ( ) www.reuters.com   time to read: +1 min
April 4 (Reuters) - Washington state's government said on Tuesday it had purchased a three-year supply of abortion pill mifepristone as a Texas judge mulls a nationwide ban on the medication's sale. The state's Democratic governor directed its Department of Corrections, which has a pharmacy license, to purchase the medication last month, a government statement said. "Health care should be decided by a patient and their doctor, not a judge in Texas," Washington Governor Jay Inslee said in a tweet, adding that the purchase ensured "continued access" for all patients in his state. loadingLegal fights over abortion rights have ramped up in the United States after a Supreme Court ruling last year that overturned the landmark 1973 Roe v. Wade decision legalizing the procedure. Reporting by Kanjyik Ghosh in Bengaluru; Editing by Jamie FreedOur Standards: The Thomson Reuters Trust Principles.
March 28 (Reuters) - A federal judge in Texas on Tuesday refused to transfer to another court a lawsuit by Republican states challenging a Biden administration rule allowing socially conscious investing by retirement plans, rejecting claims of "judge shopping." U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, said the Biden administration had provided no evidence that the litigation did not belong in his court or that plaintiffs were attempting to manipulate the process. His courthouse has become a favored destination for Republicans seeking to challenge aspects of Democratic President Joe Biden's agenda. The Labor Department argues the rule is valid because it still requires retirement plans to consider traditional financial factors when choosing investments. Congress in early March voted to repeal the ESG rule, but Biden vetoed that bill.
"I found cash budgeting and I literally stuck to it," Taylor says. Posts of her managing her finances by stuffing cash into envelopes soon went viral. When Taylor began cash stuffing, she operated on a zero-based budget, which is the most common option among cash stuffers, she says. Jasmine Taylor uses cash stuffing to budget her income. Second, she realized there was a market for people like her who found cash stuffing attractive but found plain, old envelopes drab.
Of the various potential rulings possible in the case involving the abortion pill mifepristone, either of those outcomes would be unprecedented judicial intervention in the agency's regulatory process. Some of the FDA's options could be politically and legally risky both for the agency and mifepristone suppliers, they said. The FDA said the pill was deemed safe after extensive studies and use, and that the challenge comes much too late. Under FDA statutes and regulations, drug approval withdrawal generally begins with an informal hearing, which can entail extensive document preparation and the convening of an advisory committee. Overseas provider Aid Access, an Austria-based service that ships abortion medication to U.S. patients, said it would continue providing the pill no matter how the FDA responds.
Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas in Amarillo heard four hours of arguments. The anti-abortion group that filed the lawsuit, the Alliance Defending Freedom, presented their case against the FDA first. They were followed by Justice Department attorneys defending the FDA and then the abortion pill maker Danco Laboratories. The Alliance Defending Freedom argued that mifepristone is unsafe and the FDA did not properly follow its approval process when it cleared mifepristone for use in 2000.
The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. Senate Judiciary Committee | YouTubeA Texas judge will soon issue a pivotal ruling in a closely watched case challenging the Food and Drug Administration's approval of the abortion pill mifepristone. It's also possible that Kacsmaryk could order the agency to impose tighter restrictions on access to mifepristone but stop short of completely halting sales. Abortion rights groups and legal experts expect the judge will rule against the FDA in some form. Possible injunctionIf Kacsmaryk issues an order to withdraw mifepristone from the market, there are several ways such a ruling could be drafted.
AMARILLO, Texas—A federal judge is set to hear arguments Wednesday on whether to block sales of a medication used in more than half of the abortions in the U.S., the first public hearing in a case that has drawn national attention. Antiabortion medical groups and individual physicians filed a lawsuit in November, arguing that the Food and Drug Administration exceeded its authority when it approved the sale of the abortion-inducing pill known as mifepristone under a process meant for treatments of serious or life-threatening illnesses. The judge is now weighing whether to issue a preliminary injunction blocking sales of the pill while litigation continues.
March 15 (Reuters) - A U.S. judge in Texas is set to hear arguments on Wednesday in a bid by anti-abortion groups to ban sales of the abortion pill mifepristone across the country, even in states where abortion is legal, as they challenge regulatory approval granted more than two decades ago. Twelve of the 50 states now ban abortion outright while some others prohibit it after a certain length of pregnancy, according to the Guttmacher Institute, a research organization that supports abortion rights. The judge cited death threats and harassment directed at the court during the case and a wish to avoid disruption. After appealing to the 5th Circuit, the losing side could seek to take the matter to the U.S. Supreme Court. Reporting by Brendan Pierson in New York; Editing by Will Dunham and Alexia GaramfalviOur Standards: The Thomson Reuters Trust Principles.
Total: 25